Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Low-Dose Bevacizumab for PDR Vitrectomy
NCT01854593Phase 4Completed
- Sponsor
- Nihon University
- Start
- May 2012
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bevacizumab in proliferative diabetic retinopathy (PDR) (2 arms), sponsored by Nihon University. Primary endpoint: Reoperation at 1 month. Started May 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT01854593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854593.